Updated:
Fine Value
Fine Value is a venture capital firm headquartered in China. The firm's investment focus centers on the intersection of biomedical big data and artificial...
Fine Value
Fine Value is a venture capital firm headquartered in China. The firm's investment focus centers on the intersection of biomedical big data and artificial intelligence. It specifically targets innovative technology companies providing AI drug discovery (AIDD) and biological data governance solutions. Additionally, Fine Value supports the transformation of scientific research achievements into viable commercial services. Through its strategic investments, the firm aims to foster advancements in the biomedical and AI sectors. As a China-based venture capital firm, it seeks out opportunities within the rapidly evolving healthcare and technology landscapes. Fine Value leverages its expertise to back companies driving innovation in these specialized fields.
General information
Firm type
Venture Capital
Location
Country
China
City
China
Corporate office
China, China
Sector focus
Frequently asked questions
What is Fine Value?
Fine Value is a venture capital firm based in China that focuses on investments in innovative technology and biomedical sectors.
What specific areas does Fine Value invest in?
The firm invests in companies focused on biomedical big data, artificial intelligence, AI drug discovery (AIDD), biological data governance, and the transformation of scientific research achievements.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: